Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1α upregulation

被引:29
作者
Zhao, Huanxin [1 ,2 ,5 ]
Wang, Yehong [2 ]
Wu, Ye [2 ]
Li, Xiaoyu [2 ]
Yang, Guangzhao [2 ]
Ma, Xiurui [2 ]
Zhao, Rongrui [1 ,2 ]
Liu, Huirong [1 ,3 ,4 ]
机构
[1] Shanxi Med Univ, Key Lab Cellular Physiol, Chinese Educ Minist, Taiyuan 030001, Peoples R China
[2] Shanxi Med Univ, Dept Physiol, Taiyuan 030001, Peoples R China
[3] Capital Med Univ, Sch Basic Med Sci, Beijing 100069, Peoples R China
[4] Capital Med Univ, Cardiovasc Res Inst, Beijing 100069, Peoples R China
[5] Shanxi Coll Tradit Chinese Med, Taiyuan 030012, Peoples R China
关键词
hyperlipidemia; ischemic postconditioning; myocardial infarction; hypoxia inducible factor-1; ISCHEMIA-REPERFUSION INJURY; INFARCT SIZE; FACTOR-I; HYPERCHOLESTEROLEMIC RABBITS; INHIBITION; HIF-1; EXPRESSION; ANGIOGENESIS; SYSTEM; DIET;
D O I
10.1093/abbs/gmp063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperlipidemia is regarded as an independent risk factor in the development of ischemic heart disease, and it can increase the myocardial susceptibility to ischemia/reperfusion (I/R) injury. Ischemic postconditioning (Postcon) has been demonstrated to attenuate the myocardial injury induced by I/R in normal conditions. But the effect of ischemic Postcon on hyperlipidemic animals is unknown. Hypoxia inducible factor-1 (HIF-1) has been demonstrated to play a central role in the cardioprotection by preconditioning, which is one of the protective strategies except for Postcon. The aim of this study was to determine whether Postcon could reduce myocardial injury in hyperlipidemic animals and to assess whether HIF-1 was involved in Postcon mechanisms. Male Wistar rats underwent the left anterior descending coronary occlusion for 30 min followed by 180 min of reperfusion with or without Postcon after fed with high fat diet or normal diet for 8 weeks. The detrimental indices induced by the I/R insult included infarct size, plasma creatine kinase activity and caspase-3 activity. Results showed that hyperlipidemia remarkably enhanced the myocardial injury induced by I/R, while Postcon significantly decreased the myocardial injury in both normolipidemic and hyperlipidemic rats. Moreover, both hyperlipidemia and I/R promoted the HIF-1 alpha expression. Most importantly, we have for the first time demonstrated that Postcon further induced a significant increase in HIF-1 alpha protein level not only in normolipidemic but also in hyperlipidemic conditions. Thus, Postcon reduces the myocardial injury induced by I/R in normal and hyperlipidemic animals, and HIF-1 alpha upregulation may involve in the Postcon-mediated cardioprotective mechanisms.
引用
收藏
页码:745 / 753
页数:9
相关论文
共 26 条
  • [1] Expression of constitutively stable hybrid hypoxia-inducible factor-1α protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury
    Date, T
    Mochizuki, S
    Belanger, AJ
    Yamakawa, M
    Luo, ZG
    Vincent, KA
    Cheng, SH
    Gregory, RJ
    Jiang, CW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2005, 288 (02): : C314 - C320
  • [2] Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+ATP channels in both normal and hypercholesterolemic rabbits
    Donato, Martin
    D'Annunzio, Veronica
    Berg, Gabriela
    Gonzalez, German
    Schreier, Laura
    Morales, Celina
    Wikinski, Regina L. W.
    Gelpi, Ricardo J.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (05) : 287 - 292
  • [3] Experimental hyperlipidaemia does not prevent preconditioning and it reduces ischemia-induced apoptosis
    Dworakowski, Rafal
    Dworakowska, Dorota
    Kocic, Ivan
    Wirth, Tomas
    Gruchala, Marcin
    Kaminski, Maciej
    Ray, Robin
    Petrusewicz, Jacek
    Yla-Herttuala, Seppo
    Rynkiewicz, Andrzej
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 126 (01) : 62 - 67
  • [4] Hypoxia-inducible factor-1 is central to cardioprotection -: A new paradigm for ischemic preconditioning
    Eckle, Tobias
    Koehler, David
    Lehmann, Rainer
    El Kasmi, Karim C.
    Eltzschig, Holger K.
    [J]. CIRCULATION, 2008, 118 (02) : 166 - 175
  • [5] Loss of pacing-induced preconditioning in rat hearts:: Role of nitric oxide and cholesterol-enriched diet
    Ferdinandy, P
    Szilvássy, Z
    Horváth, LI
    Csont, T
    Csonka, C
    Nagy, E
    Szentgyörgyi, R
    Nagy, I
    Koltai, M
    Dux, L
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (12) : 3321 - 3333
  • [6] Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning
    Ferdinandy, Peter
    Schulz, Rainer
    Baxter, Gary F.
    [J]. PHARMACOLOGICAL REVIEWS, 2007, 59 (04) : 418 - 458
  • [7] Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: Role of matrix metalloproteinase-2 inhibition
    Giricz, Z
    Lalu, MM
    Csonka, C
    Bencsik, P
    Schulz, R
    Ferdinandy, P
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) : 154 - 161
  • [8] The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits
    Iliodromitis, Efstathios K.
    Zoga, Anastasia
    Vrettou, Agathi
    Andreadou, Ioanna
    Paraskevaidis, Ioannis A.
    Kaklamanis, Loukas
    Kremastinos, Dimitrios Th.
    [J]. ATHEROSCLEROSIS, 2006, 188 (02) : 356 - 362
  • [9] Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma
    Khatri, JJ
    Johnson, C
    Magid, R
    Lessner, SM
    Laude, KM
    Dikalov, SI
    Harrison, DG
    Sung, HJ
    Rong, Y
    Galis, ZS
    [J]. CIRCULATION, 2004, 109 (04) : 520 - 525
  • [10] Experimental hyperlipidemia prevents the protective effect of ischemic preconditioning on the contractility and responsiveness to phenylephrine of rat-isolated stunned papillary muscle
    Kocic, I
    Konstanski, Z
    Kaminski, M
    Dworakowska, D
    Dworakowski, R
    [J]. GENERAL PHARMACOLOGY, 1999, 33 (03): : 213 - 219